38533446|t|Higher serum Lp-PLA2 is associated with cognitive impairment in Parkinson's disease patients.
38533446|a|Objective: To explore the association between lipoprotein-associated phospholipase A2 (Lp-PLA2) and the risk of cognitive impairment in Parkinson's disease (PD-CI). Methods: A case-control study involving 100 hospitalized PD patients and 60 healthy controls was carried out. Serum Lp-PLA2 level was detected by automatic biochemical analyzer. Based on whether Parkinson's patients have cognitive impairment, PD patients were subdivided to analyze the clinical value of Lp-PLA2. Relationship between Lp-PLA2 and PD-CI risk was analyzed by logistic regression. Diagnostic value of Lp-PLA2 in PD-CI patients was investigated using receiver's operator characteristic curves. Results: The levels of serum Lp-PLA2 activity in Parkinson's disease with normal cognition (PD-NC) and PD-CI patients were significantly higher than those in healthy controls (HCs), respectively. Furthermore, compared to the PD-NC group, the serum Lp-PLA2 activity level was significantly higher in PD-CI patients. Multivariable logistic regression analysis indicated that higher Lp-PLA2 level was an independent risk factor for PD patients with cognitive impairment. Moreover, the area under the efficacy curve of Lp-PLA2 for predicting PD-CI is 0.659. Conclusion: Our study shows that higher levels of Lp-PLA2 activity in PD patients are associated with the risk of developing cognitive impairment. Therefore, given the wide availability, safety, and convenience of monitoring serum Lp-PLA2 activity, it may serve as an early biomarker for cognitive impairment in PD patients.
38533446	13	20	Lp-PLA2	Gene	7941
38533446	40	60	cognitive impairment	Disease	MESH:D003072
38533446	64	83	Parkinson's disease	Disease	MESH:D010300
38533446	84	92	patients	Species	9606
38533446	140	179	lipoprotein-associated phospholipase A2	Gene	7941
38533446	181	188	Lp-PLA2	Gene	7941
38533446	206	226	cognitive impairment	Disease	MESH:D003072
38533446	230	249	Parkinson's disease	Disease	MESH:D010300
38533446	251	256	PD-CI	Disease	MESH:D010300
38533446	316	318	PD	Disease	MESH:D010300
38533446	319	327	patients	Species	9606
38533446	375	382	Lp-PLA2	Gene	7941
38533446	454	465	Parkinson's	Disease	MESH:D010300
38533446	466	474	patients	Species	9606
38533446	480	500	cognitive impairment	Disease	MESH:D003072
38533446	502	504	PD	Disease	MESH:D010300
38533446	505	513	patients	Species	9606
38533446	563	570	Lp-PLA2	Gene	7941
38533446	593	600	Lp-PLA2	Gene	7941
38533446	605	610	PD-CI	Disease	MESH:D010300
38533446	673	680	Lp-PLA2	Gene	7941
38533446	684	689	PD-CI	Disease	MESH:D010300
38533446	690	698	patients	Species	9606
38533446	794	801	Lp-PLA2	Gene	7941
38533446	814	833	Parkinson's disease	Disease	MESH:D010300
38533446	857	859	PD	Disease	MESH:D010300
38533446	868	873	PD-CI	Disease	MESH:D010300
38533446	874	882	patients	Species	9606
38533446	990	992	PD	Disease	MESH:D010300
38533446	1013	1020	Lp-PLA2	Gene	7941
38533446	1064	1069	PD-CI	Disease	MESH:D010300
38533446	1070	1078	patients	Species	9606
38533446	1145	1152	Lp-PLA2	Gene	7941
38533446	1194	1196	PD	Disease	MESH:D010300
38533446	1197	1205	patients	Species	9606
38533446	1211	1231	cognitive impairment	Disease	MESH:D003072
38533446	1280	1287	Lp-PLA2	Gene	7941
38533446	1303	1308	PD-CI	Disease	MESH:D010300
38533446	1369	1376	Lp-PLA2	Gene	7941
38533446	1389	1391	PD	Disease	MESH:D010300
38533446	1392	1400	patients	Species	9606
38533446	1444	1464	cognitive impairment	Disease	MESH:D003072
38533446	1550	1557	Lp-PLA2	Gene	7941
38533446	1607	1627	cognitive impairment	Disease	MESH:D003072
38533446	1631	1633	PD	Disease	MESH:D010300
38533446	1634	1642	patients	Species	9606
38533446	Association	MESH:D003072	7941
38533446	Association	MESH:D010300	7941

